STING1 and cancer: The effective activation of STING1 by various agonists stimulates ICD-mediated antitumor immunity in colon carcinoma cells176, neuroblastoma cells119, and melanoma cells177 by producing highly immunogenic cancer cell debris or type I IFNs (Fig. 5).